CARRIE EURE: Open Payments
NPI 1154789717 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 18 payments from 11 companies in 2025. Trend: 2023 $479 · 2024 $683 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $144 |
| Medtronic, Inc. | 1 | $100 |
| ABBVIE INC. | 5 | $92 |
| Davol Inc. | 1 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Myriad Genetic Laboratories, Inc. | 1 | $31 |
| Organogenesis Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Smith+Nephew, Inc. | 1 | $19 |
Products named: ZEPBOUND, PROGRIP, DALVANCE, Phasix Mesh, GATTEX, MYRISK, AFFINITY, IRRISEPT.
Industry payments across MS — which companies pay providers there.
